Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears IND for ASC-618 gene therapy for hemophilia A

July 8, 2021

Dosing starts in phase I/II study of Moderna's quadrivalent seasonal flu mRNA vaccine

July 8, 2021

Atossa receives approval to open phase I/II study of AT-H201 in Australia

July 8, 2021

CXD-101 demonstrates promising early clinical data in its China IND program

July 8, 2021

LY-3305677 is safe and shows body weight-lowering effect in FIH trial

July 8, 2021

To close or not to close: Astrocytes influence brain plasticity by controlling critical period

July 8, 2021

Researchers at University of Oxford initiate phase I study of HIVconsvX vaccine

July 8, 2021

Centivax patents CR-3022-derived antibodies for SARS-CoV-2

July 8, 2021

Chiesi Farmaceutici synthesizes new LPAR2 antagonists

July 8, 2021

Shaanxi Synthetic Pharmaceutical identifies new antibacterials

July 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...